Atlas Trials

Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients

Clinical trial NCT06479460 · UNKNOWN

Trial details

NCT number
NCT06479460
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast CancerNeoadjuvantHER2-positive Breast CancerCirculating Tumor DNA
Start date
2024-03-08
Primary completion
2025-05-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.